Pictet Asset Management (UK)’s Filana Therapeutics FLNA Stock Holding History

Pictet Asset Management (UK)’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$206K	Buy	+2,409	New	+$129K	﹤0.01%	1631
2014 Q3	–	Sell	-44,900	Closed	-$1.81M	–	882
2014 Q2	$1.81M	Buy	44,900 +14,514	+48%	+$537K	0.01%	753
2014 Q1	$1.17M	Buy	30,386 +2,072	+7%	+$73.1K	0.01%	776
2013 Q4	$963K	Buy	+28,314	New	+$752K	﹤0.01%	780

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Pictet Asset Management (UK)'s FLNA Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Filana Therapeutics (FLNA) in Q2 2021: 2,409 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #1631 among its holdings. This is a return to the name: Pictet Asset Management (UK) previously reported a position in FLNA as recently as Q2 2014.

Pictet Asset Management (UK) first reported a position in FLNA in Q4 2013 and has held it in 4 quarters since. The position peaked at $1.81M in Q2 2014. 169 funds tracked by Wall St. Rank hold FLNA as of Q2 2021.

Pictet Asset Management (UK) held 2,409 shares of Filana Therapeutics worth $206K as of Q2 2021.
Filana Therapeutics was a new Pictet Asset Management (UK) position in Q2 2021.
Filana Therapeutics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1631 holding.
Pictet Asset Management (UK) first reported a position in Filana Therapeutics in Q4 2013 and has held it in 4 quarters since.
Pictet Asset Management (UK)'s Filana Therapeutics position peaked at $1.81M in Q2 2014.
169 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.